In 2018, 3 233 confirmed cases of invasive meningococcal disease (IMD), including 324 deaths, were reported in 30 European Union/European Economic Area (EU/EEA) Member States.
This report presents findings related to the hepatitis B and C continuum of care, policy on testing and treatment, and the impact of the COVID-19 pandemic on hepatitis services in the EU/EEA from the second data collection conducted in 2021.
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.
This report presents the results of the ECDC European Reference Laboratory Network for Pertussis (ERLNPert-Net) external quality assessment (EQA) scheme for Bordetella pertussis PCR, funded by ECDC on behalf of ERLNPert-Net and conducted from April to September 2020. The EQA was organised by the National Institute for Biological Standards and Control (NIBSC), based in Potter’s Bar, United Kingdom (UK).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 March-2 April 2022, and includes updates on COVID-19, the influx of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, seasonal influenza, Crimean-Congo haemorrhagic fever, and poliomyelitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 January 2022 and includes updates on COVID-19, the Omicron variant, avian influenza, seasonal influenza, MERS-CoV, meningitis, dengue and chikungunya.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 September 2021 and includes updates on COVID-19, West Nile virus, measles, Nipah virus, meningitis, plague and polio.